Kurs Vortag | 71,92 |
Öffnen | 71,62 |
Gebot | 71,16 x 50000 |
Briefkurs | 71,18 x 50000 |
Tagesspanne | 71,40 - 72,06 |
52-Wochen-Spanne | 54,85 - 84,73 |
Volumen | |
Durchschn. Volumen | 399 |
Marktkap. | 89,061B |
Beta (5 J., monatlich) | 0,40 |
Kurs-Gewinn-Verhältnis (roll. Hochrechn.) | 17,37 |
EPS (roll. Hochrechn.) | N/A |
Gewinndatum | N/A |
Erwartete Dividende & Rendite | 2,72 (3,78%) |
Ex-Dividendendatum | 14. Juni 2023 |
1-Jahres-Kursziel | N/A |
NORHAMPTON, MA / ACCESSWIRE / November 10, 2022 / Gilead Sciences While Jesse Garcia was growing up in Chicago's inner city, his parents didn't immediately turn to a doctor when someone in the family got sick. "We relied on traditional Latino ...
NORTHAMPTON, MA / ACCESSWIRE / November 2, 2022 / Gilead Sciences Since the beginning of the COVID-19 pandemic, Gilead's first-in-class antiviral was made available to more than 11 million patients globally- over 65% of whom live in low-and lower-middle-income ...
In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer conference and had a revelation that she refers to as her "coming-out party." She learned she had metastatic breast cancer three years earlier and although she was a retired hospice nurse, she faced the disease without any guidance from others who shared her experience.
Gilead Sciences, Inc. (Nasdaq:GILD) recently announced that the Gilead Foundation's Creating Possible Fund™ will provide a total of $20 million to 13 inaugural grantees. The Creating Possible Fund was launched to support creative and high-impact strategies that advance health through education equity, with a main focus on building a pipeline of Black health leaders.